2nd Quarter - Amendment
XOMA CORPORATION (FKA XOMA (US) LLC) for XOMA CORPORATION (FKA XOMA (US) LLC)
Income
—
Expenses
$150,000
Expense method
C: businesses, Internal Revenue Code section 162(e)
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 21, 2008 | $16,210 | Replaced |
| 2nd Quarter - Amendment (this page) | Oct 16, 2008 | $150,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Issues regarding biotechnology defense generally and specifically regarding national security; Issues regarding the HHS BARDA program and funding; Issues regarding countermeasure stockpiling.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN B ENGLE | — |
| PATRICK JEROME SCANNON | — |
| ROBERT TENEROWICZ | — |
Medical/Disease Research/Clinical Labs MED
Issues regarding anti-botulism toxin.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN CAFARO | — |
| STEVEN B ENGLE | — |
| PATRICK JEROME SCANNON | — |
| ROBERT TENEROWICZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.